World ADC San Diego 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Bionavigen at World ADC San Diego 2026

Oct 12–15, 2026 San Diego, CA ~1.3k attendees Website

Bionavigen takes part in 6 sessions at World ADC San Diego 2026 in San Diego. Its sessions centre on ADC safety and early clinical planning. They cover predicting and reducing ADC side effects from preclinical studies onward, including for non-cytotoxic payloads, and choosing patients, doses and biomarkers for first trials.

Organization	World ADC San Diego 2026 Attendance
Bionavigen
bionavigen.com Consulting & other services Consultancy advising on discovery, preclinical, translational, regulatory and early clinical development of biologics, including ADCs, bispecifics and gene therapies.	Chair Predicting, Characterizing & Mitigating ADC Toxicities to Widen Therapeutic Index Pre-conference: 7th Toxicity Day Talk Mon Oct 12 10:00am Breaking Down Toxicity Considerations for Non-Cytotoxic Payloads & Alternative Antibody Formats to Unlock Differentiated ADC Therapeutic Index Pre-conference: 7th Toxicity Day Chair Optimizing ADC Patient Selection, Dosing & Trial Design to Set Up Early ADC Clinical Development for Success Translational Medicine Panel Tue Oct 13 3:00pm Evaluating the Need for Biomarker & Patient Selection Tools in an Increasingly Busy ADC Field Translational Medicine Talk Wed Oct 14 12:30pm Presentation & Fireside Chat: Beyond Antibody, Linker & Payload – Is Intracellular Delivery the Next Frontier for ADCs? Preclinical · with Defence Therapeutics, Genentech Workshop Thu Oct 15 9:00am Translating ADC Tolerability: Deep-Diving Into Toxicity Characterization & Preclinical Strategy to Better Predict ADC Clinical Safety Profiles Post-conference workshop for Preclinical & Translational Medicine

Organization

World ADC San Diego 2026 Attendance

Bionavigen

bionavigen.com

Consulting & other services

Consultancy advising on discovery, preclinical, translational, regulatory and early clinical development of biologics, including ADCs, bispecifics and gene therapies.

Chair

Predicting, Characterizing & Mitigating ADC Toxicities to Widen Therapeutic Index

Pre-conference: 7th Toxicity Day

Talk

Mon Oct 12
10:00am

Breaking Down Toxicity Considerations for Non-Cytotoxic Payloads & Alternative Antibody Formats to Unlock Differentiated ADC Therapeutic Index

Pre-conference: 7th Toxicity Day

Chair

Optimizing ADC Patient Selection, Dosing & Trial Design to Set Up Early ADC Clinical Development for Success

Translational Medicine

Panel

Tue Oct 13
3:00pm

Evaluating the Need for Biomarker & Patient Selection Tools in an Increasingly Busy ADC Field

Translational Medicine

Talk

Wed Oct 14
12:30pm

Presentation & Fireside Chat: Beyond Antibody, Linker & Payload – Is Intracellular Delivery the Next Frontier for ADCs?

Preclinical · with Defence Therapeutics, Genentech

Workshop

Thu Oct 15
9:00am

Translating ADC Tolerability: Deep-Diving Into Toxicity Characterization & Preclinical Strategy to Better Predict ADC Clinical Safety Profiles

Post-conference workshop for Preclinical & Translational Medicine

Instantly find 20 buyers from Bionavigen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World ADC or its organizers. Submit a correction